A survey of hospitals participating in the Canadian Nosocomial Infection Surveillance Program suggests that these facilities are not adequately prepared for Candida auris, according to an article on the Healio website.
The first multidrug-resistant case of the illness was reported in the country in 2017.
To date, no program has been implemented for systematic surveillance of C. auris in Canada, and data to inform best practices in microbiology and infection prevention and control (IPAC) remain sparse, the article said.
Of the 56 hospitals, 10 had a written policy stating which patients should be screened for C. auris colonization; an additional 11 hospitals suggested some patient screening was needed.
Alleged Ransomware Administrator Extradited from South Korea
Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital
Ground Broken on New Pediatric Health Campus in Dallas
Pre-Construction Strategies for Successful Facilities Projects
Geisinger Finds Success with Violence Prevention Efforts